Skip to main content
icon for Flu Hospitalization Rate Week 28, 2026?

Flu Hospitalization Rate Week 28, 2026?

icon for Flu Hospitalization Rate Week 28, 2026?

Flu Hospitalization Rate Week 28, 2026?

Juli 24

Juli 24

86–89 99.7%

89–92 <1%

<80 <1%

80–83 <1%

Polymarket
NEU

86–89 99.7%

89–92 <1%

<80 <1%

80–83 <1%

Polymarket
NEU

<80

$569 Vol.

<1%

80–83

$567 Vol.

<1%

83–86

$577 Vol.

<1%

86–89

$4,533 Vol.

100%

89–92

$567 Vol.

<1%

92–95

$600 Vol.

<1%

95+

$568 Vol.

<1%

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Cumulative influenza-associated hospitalization rates in the 2025-2026 season reached 87.7 per 100,000 population by Week 27 (ending July 11, 2026), according to CDC FluSurv-NET data.** With activity now minimal—clinical lab positivity at 0.6% and weekly rates near 0.1 per 100,000—additional cases through Week 28 are expected to be negligible, reflecting typical off-season dynamics driven by reduced viral transmission in warmer conditions, lower indoor crowding, and school recess. Historical patterns show summer weeks contribute little to cumulative totals, which peaked earlier with H3N2 dominance. Trader consensus across narrow ranges around 80–95+ likely reflects minor uncertainty from reporting lags and potential late detections rather than meaningful shifts in incidence, as official surveillance confirms sustained low-level circulation into midsummer.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$7,980
Enddatum
24. Juli 2026
Markt eröffnet
Jul 17, 2026, 7:13 PM ET
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Cumulative influenza-associated hospitalization rates in the 2025-2026 season reached 87.7 per 100,000 population by Week 27 (ending July 11, 2026), according to CDC FluSurv-NET data.** With activity now minimal—clinical lab positivity at 0.6% and weekly rates near 0.1 per 100,000—additional cases through Week 28 are expected to be negligible, reflecting typical off-season dynamics driven by reduced viral transmission in warmer conditions, lower indoor crowding, and school recess. Historical patterns show summer weeks contribute little to cumulative totals, which peaked earlier with H3N2 dominance. Trader consensus across narrow ranges around 80–95+ likely reflects minor uncertainty from reporting lags and potential late detections rather than meaningful shifts in incidence, as official surveillance confirms sustained low-level circulation into midsummer.

This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.

If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.

The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.

Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Volumen
$7,980
Enddatum
24. Juli 2026
Markt eröffnet
Jul 17, 2026, 7:13 PM ET
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week. If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket. The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket. Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.

Vorsicht bei externen Links.

Häufig gestellte Fragen

„Flu Hospitalization Rate Week 28, 2026?" ist ein Prognosemarkt auf Polymarket mit 7 möglichen Ergebnissen, bei dem Händler Anteile auf Basis ihrer Einschätzung kaufen und verkaufen. Das aktuell führende Ergebnis ist „86–89" mit 100%, gefolgt von „<80" mit 0%. Die Preise spiegeln Echtzeit-Wahrscheinlichkeiten der Community wider. Ein Anteilspreis von 100¢ bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 100% zuweist. Diese Quoten ändern sich laufend, wenn Händler auf neue Entwicklungen reagieren. Anteile am richtigen Ergebnis können bei Marktauflösung für jeweils $1 eingelöst werden.

„Flu Hospitalization Rate Week 28, 2026?" ist ein neu erstellter Markt auf Polymarket, gestartet am Jul 17, 2026. Als früher Markt haben Sie die Gelegenheit, zu den ersten Händlern zu gehören, die die Quoten setzen und die ersten Preissignale des Marktes etablieren. Sie können diese Seite auch als Lesezeichen speichern, um Volumen und Handelsaktivität zu verfolgen, während der Markt an Fahrt gewinnt.

Um auf „Flu Hospitalization Rate Week 28, 2026?" zu handeln, durchsuchen Sie die 7 verfügbaren Ergebnisse auf dieser Seite. Jedes Ergebnis zeigt einen aktuellen Preis, der die implizierte Wahrscheinlichkeit des Marktes darstellt. Um eine Position einzunehmen, wählen Sie das Ergebnis, das Sie für am wahrscheinlichsten halten, wählen Sie „Ja" um dafür oder „Nein" um dagegen zu handeln, geben Sie Ihren Betrag ein und klicken Sie auf „Handeln". Liegt Ihr gewähltes Ergebnis bei Marktauflösung richtig, zahlen Ihre „Ja"-Anteile jeweils $1 aus. Liegt es falsch, zahlen sie $0. Sie können Ihre Anteile auch jederzeit vor der Auflösung verkaufen.

Der aktuelle Favorit für „Flu Hospitalization Rate Week 28, 2026?" ist „86–89" mit 100%, was bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 100% zuweist. Das nächstliegende Ergebnis ist „<80" mit 0%. Diese Quoten werden in Echtzeit aktualisiert, wenn Händler Anteile kaufen und verkaufen. Schauen Sie regelmäßig vorbei oder speichern Sie diese Seite als Lesezeichen.

Die Auflösungsregeln für „Flu Hospitalization Rate Week 28, 2026?" definieren genau, was passieren muss, damit jedes Ergebnis als Gewinner erklärt wird – einschließlich der offiziellen Datenquellen zur Bestimmung des Ergebnisses. Sie können die vollständigen Auflösungskriterien im Abschnitt „Regeln" auf dieser Seite über den Kommentaren einsehen. Wir empfehlen, die Regeln vor dem Handeln sorgfältig zu lesen, da sie die genauen Bedingungen, Sonderfälle und Quellen festlegen.